We are one of the largest global pharmaceutical sourcing and distribution services companies, helping healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. Our operations are designed to increase the effectiveness and efficiency of the pharmaceutical supply chain, which reflects our commitment to operational flexibility and adaptability in response to external pressures. The pharmaceutical distribution segment's operations provide drug distribution and related services designed to reduce healthcare costs and improve patient outcomes, showcasing our resilience strategies in navigating complex market conditions. We believe that our ability to respond effectively to environmental disruptions and transform ourselves to emerge stronger from challenging situations is critical to maintaining organizational health and performance. Our revenue growth is driven by various factors, including industry growth trends, the introduction of new innovative brand therapies, and the anticipated increase in the number of generic drugs, which illustrates our strategic response to market dynamics. The increase in revenue from our pharmaceutical distribution segment highlights our capability to absorb strain and preserve functioning despite adversity. Our operations are affected by changes in pharmaceutical manufacturer pricing and distribution policies, as well as increased downward pressure on government reimbursement rates, which necessitates continuous risk assessment and resource allocation to mitigate potential impacts on our business. We have implemented strategic initiatives to enhance our operational management and ensure business continuity, particularly in light of the ongoing changes in customer consolidation and competitive pressures. The results of operations indicate that we are effectively managing our resources to sustain growth, with significant increases in gross profit attributed to higher sales volumes and strategic partnerships. Our financial performance is also supported by our ability to adapt to changes in the competitive landscape, including the impact of federal sequestration legislation on reimbursement rates. We recognize the importance of maintaining strong relationships with key customers and suppliers to navigate the complexities of the market, which is essential for our organizational resilience. Our commitment to innovation and service delivery is evident in our diverse offerings, including pharmacy management and consulting services, which are designed to meet evolving customer needs. We continue to focus on enhancing our operational capabilities and ensuring that we are well-positioned to respond to future challenges and opportunities in the pharmaceutical industry. The strategic planning and resource management practices we employ are integral to our organizational success, enabling us to thrive in turbulent markets while maintaining a focus on long-term sustainability and growth.